Join the 'Remeron' group to help and get support from people like you.

Remeron Blog

Some Antidepressants May Raise Risk for Gastro Infection

Posted 7 May 2013 by Drugs.com

TUESDAY, May 7 – People who take certain types of antidepressants may be at higher risk for potentially deadly Clostridium difficile infection, a new study suggests. This type of infection is one of the most common caught by hospital patients and causes more than 7,000 deaths each year in the United States. Several medications are thought to increase the risk for this infection, including antidepressants. In this study, University of Michigan researchers examined C. difficile infection in people with and without depression, and found that those with major depression had a 36 percent higher risk than those without depression. Older, widowed people were 54 percent more likely to catch C. difficile than older married people. People who lived alone had a 25 percent higher risk than those who lived with others. The researchers then investigated if there was a link between antidepressants ... Read more

Related support groups: Prozac, Fluoxetine, Mirtazapine, Remeron, Sarafem, Clostridial Infection, Prozac Weekly, Rapiflux, Remeron SolTab, Selfemra

Psychiatric Drugs More Often Prescribed in the South

Posted 1 Feb 2013 by Drugs.com

FRIDAY, Feb. 1 – Use of psychiatric medications is most prevalent in the southern United States and least prevalent in the West, according to a new U.S. study. Although people living in the West are the least likely to use antipsychotics, antidepressants and stimulants, the Yale researchers found that the drugs' use is 40 percent higher in a large section of the South than in other parts of the country. The study authors attributed this discrepancy to variations in local access to health care and marketing efforts within the pharmaceutical industry. "The geographic patterns we identify are striking and map onto the patterns found for a host of other medical conditions and treatments, from cognitive decline to bypass surgery," Marissa King, assistant professor of organizational behavior at the Yale School of Management, said in a school news release. "Our work suggests that access to ... Read more

Related support groups: Depression, Bipolar Disorder, Adderall, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Seroquel, Celexa, Paxil, Phentermine, Trazodone, Vyvanse, Abilify, Citalopram, Pristiq, Lithium, Viibryd

Minorities, Medicare Recipients Less Likely to Get Antidepressants

Posted 9 Apr 2012 by Drugs.com

MONDAY, April 9 – Hispanics and blacks are less likely to be prescribed antidepressants than whites, and Medicare and Medicaid patients are less likely to receive the drugs than those with private insurance, a new study says. University of Michigan School of Public Health researchers examined data from 1993 to 2007 and found that whites were 1.5 times more likely to receive antidepressants than blacks or Hispanics with major depression. The study also found that Medicare and Medicaid patients were 31 percent and 38 percent less likely to be prescribed antidepressants than privately insured patients. Race didn't play a role in the type of antidepressants prescribed to patients, but insurance did. Medicare and Medicaid patients were 58 percent and 61 percent less likely to receive newer antidepressants than privately insured patients. Newer types of antidepressants such as serotonin ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Viibryd, Amitriptyline, Effexor XR, Sertraline, Bupropion, Fluoxetine, Savella, Venlafaxine

Prescription Meds Can Put on Unwanted Pounds

Posted 2 Mar 2012 by Drugs.com

FRIDAY, March 2 – Medications taken by millions of Americans for mood disorders, high blood pressure, diabetes and other chronic conditions can have an unhealthy side effect: weight gain. While other choices exist for some types of drugs, adjusting medications is not simply a matter of switching, said Ryan Roux, chief pharmacy officer with the Harris County Hospital District, in Houston. In the late 1990s, Dr. Lawrence Cheskin conducted early research on prescription medicines and obesity. "Some medicines make an early, noticeable difference, causing patients to become ravenously hungry, while changes are subtle for others. A few months taking them and you've gained 10 pounds," said Cheskin, now director of the Johns Hopkins Weight Management Center, in Baltimore. To help increase awareness, Roux and his pharmacist group have compiled a list of "weight-promoting" and "weight-neutral or ... Read more

Related support groups: Bipolar Disorder, High Blood Pressure, Zoloft, Diabetes, Type 2, Wellbutrin, Prozac, Prednisone, Plan B, Seroquel, Gabapentin, Metformin, Hypertension, Paxil, Sprintec, Lamictal, Mirena, Neurontin, Implanon, Metoprolol, Provera

Fear of Antidepressants Keep Many From Disclosing Depression

Posted 13 Sep 2011 by Drugs.com

TUESDAY, Sept. 13 – For a nation that seems ready to pop a pill for any ill, a new study suggests that the opposite seems true for some people with symptoms of depression, whose concerns about the side effects of antidepressants were the top reason they wouldn't disclose warning signs to their doctors. A phone survey of more than 1,000 adults who had previously participated in the California Behavioral Risk Factor Survey System, which probed depression-related beliefs, showed that 43 percent reported one or more reasons for not talking to their primary care physician about their depression. Nearly a quarter of them worried that their doctor would recommend antidepressants – the most frequently cited reason for withholding the information. Other stated barriers to sharing depressive symptoms included the belief that it's not a primary care physician's job to deal with emotional issues ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Viibryd, Amitriptyline, Effexor XR, Sertraline, Bupropion, Fluoxetine, Savella, Venlafaxine

Two Antidepressants Given to Dementia Patients Ineffective: Study

Posted 19 Jul 2011 by Drugs.com

TUESDAY, July 19 – The antidepressants most often prescribed to treat depression in dementia patients provide no appreciable relief, and may raise the risk for serious side effects, new British research suggests. "The two classes of antidepressants most likely to be prescribed for depression in Alzheimer's disease are no more effective than placebo," the study authors said. The drugs in question are Zoloft (sertraline), and Remeron (mirtazapine). "In our study, there were more adverse reactions in individuals treated with antidepressants than there were with placebo," the research team added. "Clinicians and investigators need to reframe the way they think about the treatment of people with Alzheimer's disease who are depressed, and reconsider routine prescription of antidepressants." Led by Sube Banerjee of the Institute of Psychiatry at Kings College London in England, the authors ... Read more

Related support groups: Depression, Zoloft, Remeron, Dementia, Alzheimer's Disease

Antidepressant Use Rising as Psychotherapy Rates Fall

Posted 6 Dec 2010 by Drugs.com

MONDAY, Dec. 6 – Even as fewer Americans have sought psychotherapy for their depression, antidepressant prescription rates have continued to climb in recent years, a new survey reveals. "This is an encouraging trend as it suggests that fewer depressed Americans are going without treatment," said study author Dr. Mark Olfson, a professor of clinical psychiatry at Columbia University/New York State Psychiatric Institute in New York City. "At the same time, however, the decline in psychotherapy raises the possibility that many depressed patients are not receiving optimal care." "While progress is being made in increasing the availability of depression care, a mismatch is opening up between clinical evidence and practice," Olfson cautioned. "For many depressed adults and youth, a combination of psychotherapy and antidepressants is the most effective approach. Yet, only about one-third of ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Amitriptyline, Effexor XR, Sertraline, Bupropion, Fluoxetine, Savella, Venlafaxine, Wellbutrin XL

Antidepressant Use in U.S. Has Almost Doubled

Posted 16 Dec 2009 by Drugs.com

MONDAY, Aug. 3 – Antidepressant use among United States residents almost doubled between 1996 and 2005, along with a concurrent rise in the use of other psychotropic medications, a new report shows. The increase seemed to span virtually all demographic groups. "Over 10 percent of people over the age of 6 were receiving anti-depression medication. That strikes me as significant," said study author Dr. Mark Olfson, a professor of clinical psychiatry at Columbia University/New York State Psychiatric Institute in New York City. According to background information in the study, antidepressants are now the most widely prescribed class of drugs in the United States. The expansion in use dates back to the 1980s, with the introduction of the antidepressant Prozac (fluoxetine). The study found that 5.84 percent of U.S. residents aged 6 and over were using antidepressants in 1996, compared with ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Amitriptyline, Effexor XR, Sertraline, Bupropion, Fluoxetine, Savella, Venlafaxine, Wellbutrin XL

Psych Drugs Gaining Widespread Acceptance

Posted 16 Dec 2009 by Drugs.com

FRIDAY, July 31 – A growing number of Americans now have a positive opinion on psychiatric medications, a new study contends. About five out of six people surveyed felt psychiatric medications could help people control psychiatric symptoms, but many also expected the medications could help people deal with day-to-day stresses, help them feel better about themselves and make things easier with family and friends. "People's attitudes regarding psychiatric medications became more favorable between 1998 and 2006," said study author Dr. Ramin Mojtabai, an associate professor in the department of mental health at Johns Hopkins Bloomberg School of Public Health in Baltimore. Mojtabai expressed concern, however, that people's attitudes were increasingly positive, even in situations where there might not be a proven benefit to the drugs. "My hope would be for people to be more discriminating in ... Read more

Related support groups: Anxiety, Depression, Generalized Anxiety Disorder, Panic Disorder, Bipolar Disorder, Insomnia, Anxiety and Stress, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Obsessive Compulsive Disorder, Citalopram, Pristiq, Social Anxiety Disorder

Psychotropic Medications Associated With Risk of Falls in Older Adults

Posted 1 Dec 2009 by Drugs.com

CHICAGO, Nov. 23, 2009 - Older adults who take several types of psychotropic medications—such as antidepressants or sedatives—appear more likely to experience falls, according to an analysis of previous studies reported in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. More than 30 percent of individuals older than 65 will fall at least once a year, and falls and their complications are the fifth-leading cause of death in the developed world, according to background information in the article. Each year, 85 percent of all injury-related hospital admissions and more than 40 percent of nursing home admissions are related to falls, and the annual costs related to falls and their complications are estimated to be in the billions of dollars worldwide. Both internal and external risk factors contribute to falls, and medications have previously been i ... Read more

Related support groups: Xanax, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Klonopin, Celexa, Paxil, Ambien, Trazodone, Valium, Ativan, Clonazepam, Citalopram, Pristiq, Amitriptyline, Effexor XR, Lorazepam

FDA Medwatch Alert: Remeron (mirtazapine)

Posted 8 Jul 2005 by Drugs.com

[UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject of a June 30, 2005 Public Health Advisory issued about the risk of suicidality (suicidal thinking or behavior) in adults being treated with antidepressant medications.[Posted 07/01/2005] In response to recent scientific publications that report the possibility of increased risk of suicidal behavior in adults treated with antidepressants, the FDA has issued a Public Health Advisory to update patients and healthcare providers with the latest information on this subject. Even before the publication of these recent reports, FDA had already begun the process of reviewing available data to determine whether there is an increased risk of suicidal behavior in adults taking antidepressants. The ... Read more

Related support groups: Remeron

FDA Medwatch Alert: Antidepressant Medication Products

Posted 2 May 2007 by Drugs.com

[Posted 05/02/2007] FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information for their products to include warnings about the increased risks of suicidal thinking and behavior in young adults ages 18 to 24 years old during the first one to two months of treatment. The proposed labeling changes also state that scientific data did not show this increased risk in adults older than 24 years of age and that adults 65 years of age and older taking antidepressants have a decreased risk of suicidality. The proposed updates apply to the entire category of antidepressants. Individuals currently taking prescribed antidepressant medications should not stop taking them and should notify their healthcare professional if they have concerns. Manufacturers of antidepressant ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Effexor, Prozac, Seroquel, Celexa, Paxil, Elavil, Remeron, Luvox, Anafranil, Nardil, Parnate, Symbyax, Tofranil, Aplenzin, Serzone, Limbitrol

FDA Medwatch Alert: Public Health Advisory: Antidepressant Use in Children, Adolescents, and Adults

Posted 22 Mar 2004 by Drugs.com

The FDA asked manufacturers of the following antidepressant drugs to include in their labeling a Warning statement that recommends close observation of adult and pediatric patients for worsening depression or the emergence of suicidality when treated with these agents. The drugs that are the focus of this new Warning are: Prozac (fluoxetine); Zoloft (sertraline); Paxil (paroxetine); Luvox (fluvoxamine); Celexa (citalopram); Lexapro (escitalopram); Wellbutrin (bupropion); Effexor (venlafaxine); Serzone (nefazodone); and Remeron (mirtazapine).[March 22, 2004 Public Health Advisory - FDA][March 22, 2004 Drug Information Page - FDA] Read more

Related support groups: Depression, Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Remeron, Luvox, Aplenzin, Serzone

FDA Medwatch Alert: Public Health Advisory - Suicidality in Pediatric Patients Treated with Antidepressants for Major Depressive Disorder

Posted 27 Oct 2003 by Drugs.com

The FDA notified healthcare professionals of reports of the occurrence of suicidality (both suicidal ideation and suicide attempts) in clinical trials for various antidepressant drugs in pediatric patients with major depressive disorder (MDD). FDA has completed a preliminary review of such reports for 8 antidepressant drugs (citalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, and venlafaxine) studied under the pediatric exclusivity provision, and has determined that additional data and analysis, and also a public discussion of available data, are needed. FDA plans to hold an advisory committee meeting before the Psychopharmacologic Drugs Advisory Committee and the Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee on February 2, 2004. [October 27, 2003 Public Health Advisory - FDA][October 27, 2003 Talk Paper - FDA] Read more

Related support groups: Zoloft, Effexor, Prozac, Celexa, Paxil, Remeron, Luvox, Serzone

Zoloft, Lexapro the Best of Newer Antidepressants

Posted 29 Jan 2009 by Drugs.com

THURSDAY, Jan. 29 – Sertraline (Zoloft) and escitalopram (Lexapro) are the best of 12 new-generation antidepressants, while reboxetine is the least effective, a new analysis shows. The Italian researchers reviewed 117 studies that included more than 25,000 patients with major depression to come to this conclusion. The drugs tested in the trials were bupropion (Wellbutrin/Zyban), citalopram (Celexa), duloxetine (Cymbalta), escitalopram, fluoxetine (Prozac), fluvoxamine (Luvox), milnacipran (Savella), mirtazapine (Remeron), paroxetine (Paxil), reboxetine (Edronax/Vestra), sertraline, and venlafaxine (Effexor). Based on their analysis, the review authors concluded sertraline and escitalopram were the best antidepressants overall in terms of efficacy and patient acceptability. Sertraline was found to be more effective than duloxetine by 30 percent, fluvoxamine (27 percent), fluoxetine (25 ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Effexor, Prozac, Celexa, Paxil, Remeron, Luvox, Symbyax, Aplenzin

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Depression, Major Depressive Disorder

Remeron Patient Information at Drugs.com